Written resources

Listed below are our written resources.

 Indicates a resource containing technical content written for a health professional audience.

Most of these resources are PDF files.  Click the Adobe Reader image to visit the Adobe website and download the free PDF file viewer software  .

To search for a particular written resource, use the search box below. 

Concerns and questions

  • Aluminium in vaccines Factsheet (23.48 KB)
  • Animal derived products in vaccines Factsheet (433.88 KB)
  • Homoeopathy and vaccination Factsheet (58.71 KB)
  • Immunisation benefits and risks Factsheet (28.65 KB)
  • The facts about childhood vaccines Factsheet (908.56 KB)
  • Thimerosal: What you should know Factsheet (192.65 KB)
  • Thiomersal and vaccines Factsheet (64.45 KB)
  • Vaccination during breastfeeding Factsheet (23.42 KB)
  • Health Professionals
  • Vaccine ingredients Factsheet (1.04 MB)
  • Vaccines, asthma and allergy Factsheet (54.62 KB)
  • Adverse events following immunisation

  • Anaphylaxis and vaccination Factsheet (271.21 KB)
  • Health Professionals
  • Hyperventilation Factsheet (244.94 KB)
  • Health Professionals

    Programme and schedule information

  • In The Loop (1.9 MB)
  • Health Professionals
  • Pre/Post Splenectomy Immunisation Programme Forms/Schedules (147.99 KB)
  • Health Professionals

    Cold chain

    Health Professionals

    A clinic based quality tool to support you in maintaining high cold chain standards. The guide enables providers to have instant access to temperature-recording charts at the refrigerator site, use the trouble shooting tips for cold chain problems, have a self audit tool to check your clinic is on target for excellence, keep track of your clinic’s cold chain history and use for orientation of new staff.

  • Cold Chain Policy Template 2013 Forms/Schedules (271.5 KB)
  • Health Professionals

    This template provides the information required to assist immunisation providers to develop their own cold chain management policy.

    Health Professionals

    A pictorial guide for reading the TagAlert® and recording the information and answers to frequent questions about this change to the National Cold-chain Audit.

    Health Professionals

    These guidelines are for practices to ensure that vaccines delivered within New Zealand have been stored correctly to maximise their effectiveness. These guidelines supercede the Vaccine Storage and Distribution National Standards 2002 and supplement the cold chain policy in the Immunisation Handbook 2011.

  • The essential cold chain Factsheet (246.26 KB)
  • Health Professionals

    This fact sheet summarises the most important requirements for maintenance of the vaccine cold chain.

    Ministry of Health faxes

    Reports about immunisation

    The 2013 Immunisation Health Report was commissioned by the Meningitis Foundation and Pfizer and designed to be a handy guide for parents and anyone interested in the immunisation of our tamariki. The Report provides a snapshot about what New Zealanders think about vaccines.

    In 2009 the Institute of Medicine was tasked, by the Health Resources and Services Administration in the U.S., to convene a committee of experts to review the epidemiologic, clinical, and biological evidence regarding adverse health events associated with specific vaccines including varicella zoster vaccine; influenza vaccines; hepatitis B vaccine; human papillomavirus vaccine (HPV); tetanus toxoid-containing vaccines other than those containing the whole cell pertussis component; measles, mumps, and rubella vaccines; hepatitis A vaccine; and meningococcal vaccines. The focus was only on the assessment of risk of vaccines. The prepublication copy: uncorrected proof is available on line. (Institute of Medicine of the National Academies, 25 August 2011)

    This report publishes findings of research that explored parent's decisions and reasons for delaying their baby's immunisations and tested messages that encourage and support parents to immunise on time.

    Following on from the Adverse effects of vaccines: Evidence and causality report, the Institute of Medicine was tasked, by the Department of Health and Human Services in the U.S., to convene a committee of experts to identify scientific findings and stakeholder concerns about the safety of the current U.S. childhood immunisation schedule and identify research approaches, methodologies, and study designs that could inform this question. The prepublication copy: uncorrected proof is available on line. (Institute of Medicine of the National Academies, 16 January 2013)

    Government Response to Report of the Health Committee on Inquiry into how to improve completion rates of childhood immunisation, and Briefings from the Chief Coroner on the coronial process, from Dr Michael Tatley on the adverse reaction process, and from Professor Sir Peter Gluckman on how to improve completion rates of childhood immunisation, presented to the House of Representatives in accordance with Standing Order 248 (J.1) (22 June 2011)

  • Health Committee Inquiry Report Report (181.95 KB)
  • Inquiry into how to improve completion rates of childhood immunisation, and Briefings from the Chief Coroner on the coronial process, from Dr Michael Tatley on the adverse reaction process, and from Professor Sir Peter Gluckman on how to improve completion rates of childhood immunisation (I.6E) (24 March 2011)

    This report publishes findings of research that evaluated the implementation of the Human Papillomavirus (HPV) Immunisation Programme to assess how well it is achieving its short-term goals, objectives and implementation priorities of the HPV Immunisation Programme, the evaluation placed emphasis on assessing whether an equitable vaccination programme was implemented with the long-term view of reducing inequalities in cervical cancer.

  • Immunisation Audience Research Report (673.5 KB)
  • This report publishes findings of research that explored attitudes and beliefs, decision-making processes and barriers to immunisation amongst parents/caregivers who have not fully immunised one or more of their children aged 0–5 years.

    Health Professionals

    The recommendations of this report, written by Tim Corbett and funded by GlaxoSmithKline, are aimed at increasing the level of comfort whānau experience in General Practice through proactive, whānau based communication and service enhancement approaches.

  • Targeting Immunisation Report (665.81 KB)
  • A report on New Zealand's progress towards the immunisation targets of 85% of two-year-olds fully immunised by July 2010, 90% by July 2011 and 95% by July 2012 (Ministry of Health, March 2011)